In this episode, we explore the evolving role of surrogate endpoints in the management of IgA nephropathy (IgAN), with a particular focus on the significance of estimated glomerular filtration rate (eGFR). Of the completed Phase 3 trials in IgAN, one used time-weighted average eGFR, an area under the curve-based measure that reflects the average change in eGFR from baseline over a specified period, in this case, over the full 2-year study period. The other trial used total eGFR slope to describe the overall rate of change over 2 years. But what do these endpoints mean outside the setting of a clinical trial? Expert insights shed light on how proteinuria and eGFR trends can inform prognosis and guide treatment decisions in clinical practice over the long term. Listeners will gain a deeper understanding of how to interpret eGFR changes over time and apply this knowledge to optimize patient care. Designed for nephrology professionals, this episode offers practical, evidence-based perspectives on integrating these surrogate endpoints into the care of patients with IgAN. Supported by Calliditas Therapeutics Upon completion of the podcast, please take a moment to complete a brief survey: https://kidneyforms.tfaforms.net/4728109
Chronic kidney disease (CKD) affects more than 35 million U.S. adults, yet only a small percentage see a dietitian before starting dialysis. In this episode of Kidney Commute, experts and a patient share how Medical Nutrition Therapy (MNT) can slow CKD progression, improve quality of life, and support patients in making sustainable dietary changes. Listeners will also gain practical insights on insurance coverage, referral pathways, and strategies to expand access to renal nutrition care.
In this Kidney Commute: Pitstop episode, host Dr. Osama El Shamy speaks with Drs. Susie Hu and Anthony Chang about the first AJKD Core Curriculum update since 2016 on localized renal masses. They unpack risk factors, incidental findings, treatment strategies, and the vital role nephrologists play—alongside urology and pathology—in preserving kidney function and improving patient care. AJKD Article: https://www.ajkd.org/article/S0272-63862500973-4/fulltext
Join host Dr. Sam Kant and experts Dr. Craig Gordon and Dr. Pranav Garimella as they break down the latest AJKD Core Curriculum on Autosomal Dominant Polycystic Kidney Disease (ADPKD). This episode explores genetics, imaging, prognostic tools, lifestyle strategies, and management, offering practical, evidence-based insights to guide kidney care professionals. AJKD Article: Autosomal Dominant Polycystic Kidney Disease: Core Curriculum 2025 - American Journal of Kidney Diseases
In this Kidney Commute episode, host Dr. Nupur Gupta is joined by Dr. Vandana Dua Niyyar, Cheryl Cress, RN, CNN, and home dialysis patient Jane DeMeis with her care partner Joe. They explore challenges and solutions in vascular access for home hemodialysis, including access types, self-cannulation, patient education, and real-world impacts. This interprofessional discussion blends clinical expertise and lived experience to improve patient outcomes. This episode offers CME/CE credit to eligible listeners through August 12, 2027. If you'd like to claim credit, please go to kidney.org/podcast-CE to register for this episode and complete requirements.
This episode delves into the updated AJKD Core Curriculum on Continuous Kidney Replacement Therapies (CKRT). Host Anna Gaddy is joined by authors J. Pedro Teixeira, Swapnil Hiremath and Edward Clark, as they explore crucial topics like the practical advantages and disadvantages of CRRT, mechanisms of hemodynamic instability with KRT, and strategies for de-escalation. This episode provides valuable insights into the evolving world of kidney care and addresses key considerations for nephrology professionals. The full article can be found on the AJKD website here: https://www.ajkd.org/article/S0272-63862401120-X/fulltext
In this episode of the Kidney Commute: Pitstop* series, host, Raphy Rosen is joined by Christine Corbett and Alvin Moss to discuss active medical care without dialysis. Host: Raphy Rosen, MD, FNKF Guests: Christine Corbett, DNP, APRN, FNP-BC, CNN-NP, ACHPN, FNKF & Alvin Moss, MD, FACP, FAAHPM Please visit https://www.kidney.org/podcasts/kidney-commute to view additional resources. *The Kidney Commute: Pitstop series was previously known as the NKF Life as a Nephrology Professional podcast.
Discover expert insights on kidney stone prevention and management in this episode featuring a physician, dietitian, pharmacist, and patient. Learn about key kidney stone risk factors and explore how dietary adjustments can reduce stone recurrence. Experts discuss fluid intake strategies, medication considerations, surgical indications, and even unconventional questions about roller coasters’ impact on stone passage. Tune in for actionable advice, myth-busting discussions, and interprofessional perspectives. This episode offers CME/CE credit to eligible listeners. If you'd like to claim credit, please go to kidney.org/podcast-CE to register for this episode and complete requirements.
Palliative care, or treatment focused on symptom management and quality of life, is an important and often overlooked aspect of care for people with kidney disease. Similarly, conservative treatment of advanced kidney disease, or medical management without dialysis or transplantation, is not well understood by patients and care providers alike. In this episode of the Kidney Commute, our interprofessional team discusses these two important aspects of kidney disease care. This episode offers CME/CE credit to eligible listeners. If you'd like to claim credit, please go to kidney.org/podcast-CE to register for this episode and complete requirements.
Cancer is the leading cause of death in the world, associated with high morbidity and mortality. This episode discusses how kidneys are affected by cancer and its treatment. Panelists discuss diagnosing and managing complex kidney problems, such as acute kidney injury associated with cancer and novel oncological therapies, as well as summarize drug dosing in patients with cancer. Thanks for joining us on this ride of the Kidney Commute. This episode offers CME/CE credit to eligible listeners. If you'd like to claim credit, please go to kidney.org/podcast-CE to register for this episode and complete requirements.
2025 will bring BIG changes to the dialysis world. As of Jan 01, oral phosphorus binders will be part of the dialysis payment bundle, out-of-pocket costs for prescription medications are changing in amounts and payment models, and coverage for certain dental services is expanding, to name a few. In this episode we will explore how these changes will likely impact patients, nephrologists, and dialysis units. Thanks for joining us on this ride of the Kidney Commute! This episode offers CME/CE credit to eligible listeners. If you'd like to claim credit, please go to kidney.org/podcast-CE to register for this episode and complete requirements.
Patients and care team members often encounter challenges faced by individuals from different cultural backgrounds regarding access to kidney transplantation. This episode explores the impact of a culturally sensitive approach to living donation. Panelists will discuss resources to assist with approaching these conversations effectively while taking into consideration patient-specific factors such as culture, ethnicity, language and religious beliefs. Thanks for joining us on this ride of the Kidney Commute. This episode offers CME/CE credit to eligible listeners. If you'd like to claim credit, please go to kidney.org/podcast-CE to register for this episode and complete requirements.
Do all patients with chronic kidney disease (CKD) need potassium restriction? In this episode we will explore the current guidelines of potassium intake in different CKD populations. Apart from the guidelines, we will explore the potassium concentration in foods and some tips and tricks for counseling patients. After listening to this episode, you will be in a better position to talk to patients about their potassium needs. Thanks for joining us on this ride of the Kidney Commute. This episode offers CME/CE credit to eligible listeners. If you'd like to claim credit, go to kidney.org/podcast-CE to register for this episode and complete requirements.
People with kidney disease are at an increased risk for atherosclerotic cardiovascular disease, or ASCVD, and cardiovascular disease is the leading cause of death in people with kidney disease. In this episode of the Kidney Commute our interprofessional panel of experts discusses what ASCVD is, how patients can be evaluated for their ASCVD risk, and strategies for managing and reducing this risk. We cover risk calculators, pharmaceutical options, communication strategies, and areas where we can all work together to educate patients about risk. Thank you for joining us on this ride of The Kidney Commute! Click here to claim CE Credit.
In this episode of the Kidney Commute podcast, panelists delve into the role of glucagon-like peptide-1 (GLP-1) receptor agonists in chronic kidney disease. The discussion explores the mechanisms of GLP-1 receptor agonists, their benefits in managing both kidney disease and related comorbidities like diabetes and cardiovascular disease, and the latest evidence supporting their use. Panelists also address practical challenges faced by both patients and providers. Click here to claim CE Credit.
Home hemodialysis (HHD) is hemodialysis that is performed at home entirely by a patient or with assistance from a care partner. Solo HHD is when a person performs their own hemodialysis at home without a care partner present. Solo HHD can be challenging for patients and requires the whole care team coming together with the patient to develop an individualized approach for each patient in order to increase their likelihood of success. This episode will discuss common safety concerns and other barriers to solo HHD encountered by patients and offer some potential strategies for overcoming these. Click here to claim CE credit.
Join our team in a discussion about diagnosis and treatment of glomerulonephritis, a common cause of kidney failure. We explore new treatment options and ways to engage patients in conversations about these options. Additionally, we unpack how to diagnose and monitor glomerulonephritis. This discussion also includes challenges faced both by patients and providers with regard to glomerulonephritis, especially for women of child-bearing age. Click here to claim CE credits.
The management of patients living with kidney disease is evolving as the complexity of patient care evolves. Join us as we discuss the team of clinicians who are involved in the care of patients with kidney disease, including nephrologists and advanced practice providers (APPs) - advanced practice registered nurses (APRNs) and physician assistants (PAs). This episode will review the roles of each provider type and what each brings to the team as well as the patients. It will also highlight the strengths of team-based care as well as what patients and their families can expect from an APP during clinic visits, hospitalizations, transplant workups, and on dialysis units. Click here to claim CE credits.
Many people start the year full of hope and ready to start anew. Join our team in a discussion about the best times to implement new goals relative to CKD. We also explore home dialysis modalities and ways to engage patients in conversations about this option. Additionally, we unpack how and when to implement exercise programs and include tips on tackling social isolation. We hope you enjoy this podcast as you continue in this new year. Click here to claim CE credits.
Join us for a robust discussion surrounding the ever-growing field of vitamins and supplements. This episode dives into the indications and contraindications for people with all stages of chronic kidney disease, including those on dialysis as well as those who have had a transplant. The panelists will also review the potential drug interactions and side effect profiles of the most commonly inquired about supplements. Which vitamins may be appropriate and when will be included in this episode as well. Click here to claim CE credits.